Operationalizing Innovation at Scale

In this episode, Todd Dunn, CEO of Accuryn, joins Scott Becker to discuss why acute kidney injury is now designated as a hospital harm and what that means for quality, cost, and patient outcomes. He shares insights on blind spots in kidney care, the limits of legacy tools, and how automation and monitoring can reduce harm while easing clinician burden.

This episode is sponsored by Accuryn.